Akèy › Limfòm Burkitt › Washington › Spokane
Etid klinik pou Limfòm Burkitt nan Spokane, WA
4 etid pou Limfòm Burkitt ap chèche patisipan nan sit nan ak bò kote Spokane (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
Ap rekriteFaz 2
- Providence Sacred Heart Medical Center and Children's Hospital, Spokane
Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia
Ap rekriteFaz 2
- Providence Sacred Heart Medical Center and Children's Hospital, Spokane
A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)
Ap rekriteFaz 2
- Providence Sacred Heart Medical Center and Children's Hospital, Spokane
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
Ap rekriteFaz 3
- Providence Sacred Heart Medical Center and Children's Hospital, Spokane
Etid Limfòm Burkitt nan lòt vil
- Houston, TX21 etid
- Milwaukee, WI16 etid
- Philadelphia, PA16 etid
- New York City, NY14 etid
- Chicago, IL14 etid
- Cincinnati, OH12 etid
- Atlanta, GA12 etid
- Seattle, WA11 etid
- Boston, MA10 etid
- Durham, NC10 etid
- Aurora, CO10 etid
- Los Angeles, CA10 etid
Lòt etid nan Spokane
- Kansè Poumon ki pa ti selil12 etid
- Kansè nan tete8 etid
- Kansè ovè8 etid
- Kansè kolorektal8 etid
- Maladi Parkinson7 etid
- Kansè pwostat6 etid
- Lukemi lenfositè kwonik6 etid
- Karsinòm selil skuamèz tèt ak kou6 etid
- Kansè (tout kalite)6 etid
- Kansè tete negatif triple5 etid
- Melanom5 etid
- Degeneresans makile5 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.